10.01.02
NIH To Fund Study On Tocotrienol’s Effects On Neuro-Degenerative Diseases
The National Institutes of Neurological Disorders and Stroke of the National Institute of Health (NIH) has awarded in excess of $1 million to investigate how a member of the vitamin E family—alpha-tocotrienol—helps protect against inducible neuronal cell death. This is the first-ever NIH-funded study on alpha-tocotrienol, the palm-derived form of vitamin E. The award is based on preliminary data generated using Edison, NJ-based Carotech’s Tocomin® Full Spectrum Tocotrienol Complex. Previous research on Tocomin® has determined that tocotrienols cross the blood-brain barrier, and are potent protectors of neuron cells that may be killed due to stroke and other neurodegenerative diseases. The NIH-funded study will look at the mechanism by which alpha-tocotrienol exerts its neuroprotective action. It will lay the foundation for a safe and efficient approach to preventing cell death and securing normal neural function under challenging conditions.
The National Institutes of Neurological Disorders and Stroke of the National Institute of Health (NIH) has awarded in excess of $1 million to investigate how a member of the vitamin E family—alpha-tocotrienol—helps protect against inducible neuronal cell death. This is the first-ever NIH-funded study on alpha-tocotrienol, the palm-derived form of vitamin E. The award is based on preliminary data generated using Edison, NJ-based Carotech’s Tocomin® Full Spectrum Tocotrienol Complex. Previous research on Tocomin® has determined that tocotrienols cross the blood-brain barrier, and are potent protectors of neuron cells that may be killed due to stroke and other neurodegenerative diseases. The NIH-funded study will look at the mechanism by which alpha-tocotrienol exerts its neuroprotective action. It will lay the foundation for a safe and efficient approach to preventing cell death and securing normal neural function under challenging conditions.